ISIN | LU1901191145 |
---|---|
Valor Number | 44433882 |
Bloomberg Global ID | |
Fund Name | Protea Fund-Veritas High Equity A Acc GBP |
Fund Provider | FundPartner Solutions (Europe) S.A |
Fund Provider | FundPartner Solutions (Europe) S.A |
Representative in Switzerland |
FundPartner Solutions (Suisse) SA Genève 75 |
Distributor(s) |
FundPartner Solutions (Suisse) SA Genève 3 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The Compartment’s objective is to protect and grow the purchasing power of investors’ capital over the long term by seeking global opportunities for real returns and investing on a best ideas, unindexed basis. |
Peculiarities |
Current Price * | 187.17 GBP | 10.03.2025 |
---|---|---|
Previous Price * | 189.91 GBP | 07.03.2025 |
52 Week High * | 206.16 GBP | 23.01.2025 |
52 Week Low * | 176.86 GBP | 18.04.2024 |
NAV * | 187.17 GBP | 10.03.2025 |
Issue Price * | 187.17 GBP | 10.03.2025 |
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 741,783,851 | |
Unit/Share Assets *** | 364,392,162 | |
Trading Information SIX |
YTD Performance | -3.39% |
31.12.2024 - 10.03.2025
31.12.2024 10.03.2025 |
---|---|---|
YTD Performance (in CHF) | -3.53% |
31.12.2024 - 10.03.2025
31.12.2024 10.03.2025 |
1 month | -8.74% |
10.02.2025 - 10.03.2025
10.02.2025 10.03.2025 |
3 months | -5.18% |
10.12.2024 - 10.03.2025
10.12.2024 10.03.2025 |
6 months | -0.33% |
10.09.2024 - 10.03.2025
10.09.2024 10.03.2025 |
1 year | +4.76% |
11.03.2024 - 10.03.2025
11.03.2024 10.03.2025 |
2 years | +23.41% |
10.03.2023 - 10.03.2025
10.03.2023 10.03.2025 |
3 years | +22.65% |
10.03.2022 - 10.03.2025
10.03.2022 10.03.2025 |
5 years | +69.20% |
10.03.2020 - 10.03.2025
10.03.2020 10.03.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Fiserv Inc | 4.64% | |
---|---|---|
UnitedHealth Group Inc | 4.63% | |
Mastercard Inc Class A | 3.95% | |
London Stock Exchange Group PLC | 3.88% | |
Intuitive Surgical Inc | 3.85% | |
Marsh & McLennan Companies Inc | 3.71% | |
Thermo Fisher Scientific Inc | 3.54% | |
Microsoft Corp | 3.51% | |
Intuit Inc | 3.36% | |
Synopsys Inc | 3.33% | |
Last data update | 31.10.2024 |
TER *** | 0.81% |
---|---|
TER date *** | 30.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | 0.75% |
SRRI ***
|
|
SRRI date *** | 28.02.2025 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |